Back
PDS Biotechnology Vs. Syros Pharmaceuticals Industry Stock Comparison
Sell
49
PDSB
PDS Biotechnology
Last Price:
3.50
Seasonality Move:
46.82%
Buy
88
SYRS
Syros Pharmaceuticals
Last Price:
5.55
Seasonality Move:
17.51%
Sell
49
PDS Biotechnology (PDSB)
is a Sell
Is PDS Biotechnology a Buy, Sell or Hold?
- The current PDS Biotechnology [PDSB] share price is $3.54. The Score for PDSB is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- PDSB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
88
Syros Pharmaceuticals (SYRS)
is a Buy
Is Syros Pharmaceuticals a Buy, Sell or Hold?
- The current Syros Pharmaceuticals [SYRS] share price is $5.43. The Score for SYRS is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
- SYRS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
PDSB Stock Price Chart
What is PDS Biotechnology's stock price today?
-
The PDS Biotechnology share price today is $3.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PDSB is experiencing selling pressure, which indicates risk of future bearish movement.
SYRS Stock Price Chart
What is Syros Pharmaceuticals's stock price today?
-
The Syros Pharmaceuticals share price today is $5.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRS is experiencing slight buying pressure.
PDSB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 47.85 | Sell |
| Chaikin Money Flow: | -463226 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.97 - 3.71) | Buy |
| Bollinger Bands (100): | (3.61 - 5.55) | Sell |
SYRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 53.73 | Buy |
| Chaikin Money Flow: | 59492 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.91 - 5.47) | Buy |
| Bollinger Bands (100): | (5.37 - 7.29) | Sell |
PDSB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.73 | Sell |
| 20-day SMA: | 3.41 | Buy |
| 50-day SMA: | 3.92 | Sell |
| 200-day SMA: | 4.9 | Sell |
| 8-day EMA: | 3.63 | Sell |
| 20-day EMA: | 3.57 | Sell |
| 50-day EMA: | 3.89 | Sell |
| 200-day EMA: | 4.86 | Sell |
SYRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.1 | Buy |
| 20-day SMA: | 5.1 | Buy |
| 50-day SMA: | 5.57 | Sell |
| 200-day SMA: | 4.87 | Buy |
| 8-day EMA: | 5.15 | Buy |
| 20-day EMA: | 5.19 | Buy |
| 50-day EMA: | 5.51 | Sell |
| 200-day EMA: | 5.34 | Buy |
PDS Biotechnology Earnings Growth & PDSB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.11 per share.
Syros Pharmaceuticals Earnings Growth & SYRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and a decrease next year of $0.49 per share.
PDS Biotechnology Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Syros Pharmaceuticals Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||